36309-43-0

Basic information

• Product Name: Benzenamine, 3-[(trimethylsilyl)oxy]-
• CAS NO: 36309-43-0
• Molecular Formula: C9H15NOSi
• Molecular Weight: 181.31
• Mol File: 36309-43-0.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: Benzenamine, 3-[(trimethylsilyl)oxy]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, 3-[(trimethylsilyl)oxy]-(36309-43-0)
• EPA Substance Registry System: Benzenamine, 3-[(trimethylsilyl)oxy]-(36309-43-0)

Safety Data

• Hazardous Substances Data: 36309-43-0(Hazardous Substances Data)

Upstream product

• 999-97-3 1,1,1,3,3,3-hexamethyl-disilazane 
• 591-27-5 m-Hydroxyaniline 
• 27607-77-8 trimethylsilyl trifluoromethanesulfonate 
• 3385-94-2 hexamethyldisilathiane 

Downstream Products

• 420-56-4 trimethylsilyl fluoride 
• 26740-19-2 Perfluoroctylsulfonsaeure-3-amino-phenylester 
• 32848-25-2 Perfluorbutylsulfonsaeure-3-amino-phenylester 
• 32578-28-2 (3-Aminophenyl)-trifluormethansulfonat 
• 79302-65-1 3-(trimethylsiloxy)phenyl isocyanate 
• 58334-34-2 1,1,1-Trimethyl-N-(p-trimethylsiloxyphenyl)-silylamin 
• 1612897-07-0 [(1S)-2-(3,5-dichloro-1-oxido-pyridin-1-ium-4-yl)-1-(3,4-dimethoxyphenyl)ethyl] 3-[(3-trimethylsilyloxyanhlino)methyl]benzoate 
• 1612897-09-2 C₂₉H₂₆Cl₂N₂O₆ 

Relevant articles and documents

A copper(ii)-dipicolylamine-coumarin sensor for maltosyltransferase assay

A Cu(ii)-[di(2-methylpyridyl)methylamino]coumarin fluorescence turn-on sensor (Cu-1b) is designed to detect phosphate ions with Kass = 1.4 × 105 M-1 in HEPES buffer. Cu-1b is applied to probe the GlgE-catalyzed maltose-tra

A synthetic method of 3 - (3 - hydroxyphenyl) -1, 1 -dimethylurea. Intermediate and use

The invention discloses 3 - (3 - hydroxyphenyl) -1, 1 -dimethylurea synthesis method, an intermediate and application thereof, and uses m-aminophenol as a raw material to generate HDMS, 3 - 1 dimethyl 1 (- trimethylsilyl phenyl) urea under catalysis -3 -

HETEROARYL DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES

The invention relates to novel compounds of formula (I) which are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists, methods of preparing such compounds, compositions containing them and therapeutic use thereof.